Marshall Wace’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$388K Sell
17,719
-565,414
-97% -$15.5M ﹤0.01% 2615
2026
Q2
$18.6M Buy
583,133
+385,385
+195% +$12.7M 0.01% 755
2026
Q1
$7.57M Sell
197,748
-514,143
-72% -$16.6M 0.01% 1100
2025
Q4
$18.7M Buy
711,891
+109,876
+18% +$2.02M 0.02% 653
2025
Q3
$8.42M Buy
602,015
+173,907
+41% +$1.98M 0.01% 982
2025
Q2
$4.1M Buy
428,108
+47,408
+12% +$450K ﹤0.01% 1240
2025
Q1
$3.54M Buy
380,700
+326,623
+604% +$4.23M ﹤0.01% 1210
2024
Q4
$752K Buy
54,077
+34,463
+176% +$625K ﹤0.01% 1871
2024
Q3
$461K Buy
+19,614
New +$412K ﹤0.01% 1946
2024
Q2
– Sell
-19,643
Closed -$322K – 2980
2024
Q1
$322K Sell
19,643
-10,358
-35% -$170K ﹤0.01% 2086
2023
Q4
$416K Buy
+30,001
New +$388K ﹤0.01% 1785

Other funds holding TYRA

Marshall Wace's TYRA Position: Q3 2026 in Review

Marshall Wace reduced its Tyra Biosciences (TYRA) stake by 97% in Q3 2026, selling an estimated $15.5M and leaving 17,719 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Marshall Wace first reported a position in TYRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.7M in Q4 2025. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Marshall Wace held 17,719 shares of Tyra Biosciences worth $388K as of Q3 2026.
  • Marshall Wace sold 565,414 Tyra Biosciences shares in Q3 2026, an estimated $15.5M.
  • Tyra Biosciences made up ﹤0.01% of Marshall Wace's portfolio in Q3 2026, its #2615 holding.
  • Marshall Wace first reported a position in Tyra Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Marshall Wace's Tyra Biosciences position peaked at $18.7M in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.